M3, Inc., established in Tokyo, Japan, in 2000, and formerly known as So-netM3, Inc. until its rebranding in January 2010, specializes in delivering a broad range of internet-based services, primarily targeting physicians and other healthcare professionals. The company organizes its operations across five distinct reporting divisions: Medical Platform, Evidence Solution, Career Solution, Site Solution, and Overseas. M3 manages several key digital platforms. Its flagship, m3.com, serves as an exclusive online portal providing vital information to healthcare practitioners. Through MR-kun, member doctors gain continuous and independent access to information within the m3.com ecosystem. QOL-kun offers members non-medical lifestyle support, while AskDoctors enables the general public to pose health and illness questions, which are then addressed by registered physicians. Internationally, M3 operates MDLinx for medical professionals in the United States and Doctorsnetuk, a platform that provides development services for pharmaceutical companies and hosts drug information databases for France, Germany, and Spain. Additionally, m3com CAREER facilitates career support services for medical and pharmaceutical professionals. Beyond these platforms, M3 engages in a wide array of activities, including the sales and marketing of pharmaceutical products and medical devices. The company is also involved in developing, selling, and supporting electronic medical record systems and medical equipment for healthcare facilities, conducting professional surveys for medical practitioners, and offering online sales and marketing assistance to pharmaceutical firms. Furthermore, M3 provides management support and consulting services to medical institutions, operates home-visit nursing services, supplies human resources solutions for the healthcare sector, and manages clinical research facilities.
1 Congressional buy and 1 sell on MTHRY in the last 12 months.
Unlock the full Smart Money Map — every trade plotted on the price chart with politicians, amounts and returns since each trade. Founder's Deal is $57/mo locked for life.
Unlock politician tradesWhen traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.
+5.9% YoY
YoY Growth Rate
Slow revenue growth
>+1,000% YoY
YoY Growth Rate
EPS growth accelerating
¥0/ year
0.0% of revenue
Below sector average (18%)
Research and development spending
Cash flow positive
¥236.3B cash & investments
Quarterly Free Cash Flow
Company generates more cash than it spends — no dilution risk from fundraising
M3 is growing revenue at 6% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.
The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.
The share count has stayed roughly flat over this period — little dilution or buyback activity.
Diluted shares outstanding: 1.36B (2022) → 1.35B (2026)
Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.
ROIC between 15% and 25%. Every dollar invested in the business earns 15 to 25 cents back per year.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
Earnings growing 25%+ a year. The compounder zone.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
FCF margin between 0% and 10%. Some cash from sales, but not a lot.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
Interest coverage above 8. Profits cover interest many times over.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
P/E above the market average. People are paying up for expected growth.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
Modest yield. The bulk of any return needs to come from price appreciation.
Full breakdown available with your free trial
See every metric, trend, and what it means for this stock.
